Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

43%

3 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

2(40.0%)

Phase 3

2(40.0%)

Phase 4

1(20.0%)

5Total

N/A(2)

Phase 3(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT05551182Phase 3Completed

Nicergoline Use in Dysphagia Patients

Role: collaborator

NCT06496282Phase 3Recruiting

Lemborexant on Improving Sleep Quality Among Hospital Rotating Shift Workers

Role: collaborator

NCT06049771Not ApplicableUnknown

The Population Pharmacokinetics Study of Tigecycline and Pharmacokinetics- Pharmacodynamics Index in Patients With Carbapenem Resistant Enterobacteriaceae Bloodstream Infection

Role: collaborator

NCT05862402Phase 4Unknown

Dose Optimization by Pharmacokinetic/Pharmacodynamic of Antibiotics to Improve Clinical Outcome of Carbapenem Resistant Klebsiella Pneumoniae Bloodstream Infections in Critically Ill Patients at Phramongkutklao Hospital

Role: collaborator

NCT05251584Not ApplicableUnknown

Effects of Topical Gentamicin on the Prevention of Peritoneal Dialysis Related Infection

Role: collaborator

NCT04950179Completed

PDRI Rates Among CAPD Patients at a Tertiary University Hospital: A 5-Year Retrospective Study

Role: collaborator

NCT04511676Completed

The Study of Pharmacokinetics of Levetiracetam in Patients Undergoing Intermittent Hemodialysis

Role: collaborator

All 7 trials loaded